Physician

Bradley Evanson

According to 2025 Medicare claims, Bradley Evanson (NPI: 1689069312) practices dermatology in the St. George, UT market, with the plurality of this provider's patient population coming from Washington, UT. This provider's primary affiliated billing organization is SOUTHWEST SKIN AND CANCER LLC (NPI: 1619929783; TIN: 20-4240264) and primary practice location at 84770-3620.

Evanson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,780 traditional Medicare patients, billed 12,292 HCPCS/CPT codes, and received $642,544 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 819 prescription claims across 429 beneficiaries totaling $49,971 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 30 records totaling $563. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $40,586 to $642,544. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$321K$643K2019 Medicare payment: $40,586 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $100,841 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $133,839 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $119,221 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $502,972 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $642,544 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019206647$40,586
20204281,711$100,841
20214872,221$133,839
20225871,836$119,221
20231,5969,875$502,972
20241,78012,292$642,544

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$255K$510K2015 Drug cost: $691 (USD; Tot_Drug_Cst)2016 Drug cost: $9,394 (USD; Tot_Drug_Cst)2017 Drug cost: $55,547 (USD; Tot_Drug_Cst)2018 Drug cost: $119,539 (USD; Tot_Drug_Cst)2019 Drug cost: $111,274 (USD; Tot_Drug_Cst)2020 Drug cost: $201,902 (USD; Tot_Drug_Cst)2021 Drug cost: $509,594 (USD; Tot_Drug_Cst)2022 Drug cost: $433,154 (USD; Tot_Drug_Cst)2023 Drug cost: $114,997 (USD; Tot_Drug_Cst)2024 Drug cost: $49,971 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151632$691
201669116$9,394
2017128280$55,547
2018126310$119,539
2019160371$111,274
2020209488$201,902
2021263632$509,594
2022291587$433,154
2023403733$114,997
2024429819$49,971

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth500564$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,3351,889$59
88305Pathology examination of tissue using a microscope, intermediate complexity511785$51
17000Destruction of precancer skin growth, 1 growth9441,220$36
17003Destruction of precancer skin growth, 2-14 growths8215,357$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
FluorouracilFluorouracil511,371$2,837
Clobetasol PropionateClobetasol Propionate431,246$1,240
Triamcinolone AcetonideTriamcinolone Acetonide1053,450$1,166
Doxycycline MonohydrateDoxycycline Monohydrate79934$1,025
KetoconazoleKetoconazole621,803$1,005

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.30$563ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Bradley Evanson?

Tedicare shows public-source Medicare data for Bradley Evanson (NPI 1689069312), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bradley Evanson have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Bradley Evanson?

Bradley Evanson is linked to SOUTHWEST SKIN AND CANCER LLC (billing NPI 1619929783) in the available physician profile data.

Does Bradley Evanson have Open Payments data?

Bradley Evanson has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.